Dispensing Practice Income: Where Dispensing Fees Go on Your Income Statement, and How They Are Taxed

Drug reimbursement and dispensing fees belong in turnover on your income statement, and the drugs you bought sit immediately beneath them as a cost of sale. Any drug stock unsold at the year end is a balance-sheet asset, not a cost of the year just ended. Get those three lines right and you can see what the dispensary actually contributes. Get them wrong and a six-figure turnover line flatters the accounts.

Where Do Dispensing Fees Go on Your Income Statement?

A dispensary is a business inside a business. Its numbers behave like a retailer's, with purchases, stock and a margin, while the rest of the practice runs on NHS contract income that never touches a stock ledger. That is why a single nominal code marked "dispensing" is the most common bookkeeping mistake in a dispensing practice: it collapses four different things into one line and hides the only number that matters.

Every component of a dispensing payment has one correct home in the accounts.

Where each part of a dispensing payment lands in a set of practice accounts. Structure current for 2026/27.

What arrives or is spent	Where it belongs	Why
Drug reimbursement from the NHS	Turnover, income statement	Trading income, even though most of it returns money you have already spent
Dispensing fees	Turnover, income statement	The payment for the work of dispensing each item
Quality or service payments for the dispensing service	Turnover, income statement	Contract payments for standards met in running the service
The margin adjustment, often called the clawback or discount deduction	Deducted from dispensing income	Recovers excess buying margin across the system as a whole
Drugs bought from wholesalers and suppliers	Cost of sale, income statement	Matched against the reimbursement for the drugs actually dispensed
Dispensary staff, dispensing software, fridges and storage	Practice overheads, income statement	The running cost of the dispensary itself
Drug stock on the shelves at the year end	Stock, a current asset on the balance sheet	Carried forward, because those drugs have not been dispensed yet

Read down that table and the shape of the answer appears. Your dispensing turnover is gross, your drug purchases are the offset, and the difference between them is the only part that reaches the partners.

Who Can Dispense, and Which Patients Qualify?

As a general principle, you may dispense to patients who live in a designated controlled area and more than one mile (about 1.6 km) from a pharmacy, where the patient would otherwise have serious difficulty obtaining their medicines. The detail sits in the pharmaceutical services regulations and is decided locally, so treat this as the principle and not a complete legal test.

The practical effect is that dispensing doctors are concentrated in rural England, and that you dispense to a defined group of your registered patients, never to the whole list.

The payment covers two different acts, and they are easy to blur. Every GP prescribes. Only a dispensing practice then supplies the medicine and is reimbursed for doing so. Dispensing status is a feature of the practice and the patient, never of the prescribing decision, so the same GP can write one prescription that generates dispensing income and another, for a patient on the same list, that does not.

What Is the Drug Tariff, and What Does It Pay You For?

The Drug Tariff is the national list that sets what you are reimbursed for the medicines you supply against NHS prescriptions, together with the fees, allowances and rules that go with them. NHS Prescription Services, part of the NHS Business Services Authority (NHSBSA), produces it monthly on behalf of the Department of Health and Social Care, and publishes each edition three working days before the first of the month.

The Drug Tariff NHS Prescription Services publishes covers England and Wales; Scotland and Northern Ireland run their own Drug Tariffs, published by Public Health Scotland on behalf of Scottish Ministers and by the Business Services Organisation respectively.

The distinction that matters to your accounts is what kind of payment a Tariff entry represents. A Drug Tariff price is a reimbursement price, the sum paid back to a dispensing contractor for supplying a medicine. Neither the dispensing fee nor the buying margin is inside it. The fee is a separate component with a separate purpose.

The claim itself is made by the prescription. Once the medicine has been dispensed, the prescription becomes the document you submit for pricing and payment. Hold on to that as a mental model. Every item leaving your dispensary is an invoice you have already raised, and your dispensing record is the only thing that proves what it should be worth.

No figure in the Tariff is a fixed fact. Prices are re-set monthly and the fee scale is uplifted by contract, so confirm current values at source when they matter and never carry a quoted price forward into a later year.

How Is a Dispensing Payment Actually Made Up?

The components of a dispensing payment and what each one does to profit. Structure as at 2026/27; no amount is fixed, because Drug Tariff prices are re-set monthly and the fee scale is uplifted by contract.

Component	What it pays for	Effect on profit
Drug reimbursement	The cost of the medicines you dispensed, at Drug Tariff prices	Broadly neutral, because it returns money already spent on stock
Dispensing fee	The work of dispensing each item, on a national scale	Contributes directly
Buying margin, less the margin adjustment	The gap between what you paid a supplier and the Tariff price, net of the national adjustment	Contributes whatever survives the adjustment
Quality and service payments	Standards met in running the dispensing service	Contributes directly

That third row is where the commercial pressure sits. The dispensing fee scale is uplifted by contract while drug purchase prices move with the wholesale market, so a period of rising acquisition costs compresses the margin from both ends at once. The discounts a small rural dispensary can negotiate are thinner than a large buyer's.

Dispensary staffing pushes the same way, because the dispensers, the software and the storage are fixed costs whether or not the margin holds up.

The money reaches you through the NHS channel. NHSBSA passes dispensing doctor and personal administration payment data to the payment site no later than the 15th of the month after the month it receives the prescriptions, and the actual payment date depends on local arrangements.

In England, GP payments and pension records are administered by Primary Care Support England (PCSE), with the local health board doing the equivalent job in Wales and separate arrangements in Scotland and Northern Ireland. Your dispensing line therefore lands on the same statement as the rest of your NHS income.

Checking that line against what you actually dispensed is part of a wider discipline covered in the guide to reading and reconciling PCSE statements. Dispensing sits alongside your core contract funding and your QOF income, and how the core contract itself is calculated sits on the guide to how GMS funding works.

Why Gross Dispensing Turnover Is Not Profit

Most of a dispensing payment is your own money coming back. That is the single fact that a set of dispensing accounts exists to make visible, and it is the fact a headline turnover figure destroys. A dispensing line can be the largest number in the accounts and one of the smallest contributors to what the partners take home.

Take a dispensing practice with four partners and a rounded set of illustrative figures for 2026/27. Drug reimbursement for the year is £600,000 and dispensing fees are £90,000, so gross dispensing turnover is £690,000. The drugs actually dispensed cost £575,000 to buy, leaving £115,000. The margin adjustment removes £15,000 of that.

Running the dispensary, two dispensers plus the software, fridges and storage, costs £70,000. What dispensing adds to practice profit is therefore £30,000, or £7,500 a partner on an equal share, against a turnover line of £690,000. Every figure here is illustrative and every one of them moves: the buying margin you achieve, the accuracy of your year-end stock count and the fee scale in force all change the answer.

The practical consequence is about drawings. If the partners set drawings against a turnover figure that is 95% drug cost, the practice funds the difference out of working capital and finds out at the year end.

Why Does Year-End Drug Stock Matter So Much?

Drug stock on the shelves at the year end is an asset carried forward, and only the drugs you actually dispensed during the year are a cost of that year. Counting it is therefore an accounting adjustment in its own right, and it decides how much of your drug spend belongs to the year you are reporting.

Undercount the closing stock and you charge too much drug cost to the year, understating profit. Overcount it and you overstate profit and the tax on it. In the illustration above, a £15,000 error in the count moves the dispensary's contribution by half. That error is then allocated straight out to the partners under the profit sharing agreement, so a rushed count reprices four people's tax bills.

Value the stock the same way each year, count on or as close as possible to the year-end date, and keep the count sheets. A consistent method is worth more than a theoretically perfect one applied differently in alternate years.

How Is Dispensing Income Taxed?

Dispensing profit is ordinary trading profit with no separate regime attached. It increases the partnership's taxable profit, which is allocated under the profit sharing agreement, reported on the partnership return (SA800) and taxed on each partner through the partnership pages (SA104) of their own return. A partner is taxed on their allocated profit share and never on their drawings, which is the point where a good dispensing year and a cautious drawings policy diverge.

The tax position of the different roles in a practice is set out in the comparison of GP partner and salaried GP tax, and the partnership machinery in the complete guide to GP partnership tax.

Where partners carry the dispensing risk unequally, the profit sharing agreement can allocate dispensing profit differently, which is an agreement matter and not a tax rule; the options are covered in the guide to GP partnership profit sharing.

Dispensary fit-out and equipment, meaning the shelving, fridges, dispensing robots and software, generally qualify for capital allowances and can usually be covered by the Annual Investment Allowance. The rates, the pools and what qualifies sit on the complete list of GP tax deductions, which is the place to check before a fit-out is committed.

Dispensing profit is NHS-derived, so your share of it is pensionable. A GP provider or partner reports it on the Type 1 Annual Certificate of Pensionable Profits, which is filed a year in arrears to a 28 February deadline. The certification detail sits on the guide to GP pension contributions and tax relief.

A company changes that outcome entirely, and the reasons are set out in the guide to how a company affects NHS-pensionable income.

Is VAT Charged on the Drugs You Dispense?

Drugs you dispense to a patient against an NHS prescription, for that patient to take away and use themselves, are zero-rated under VATA 1994 Schedule 8 Group 12 Item 1. Zero-rated means a taxable supply at 0%, and that distinction is worth real money, because a taxable supply lets you recover the input VAT on the drugs you bought to make it.

An exempt supply carries no recovery at all, so a practice that treats dispensed NHS drugs as exempt quietly gives away what Schedule 8 Group 12 hands it.

The zero rate follows the shape of the supply: qualifying goods, dispensed to an individual, for their own personal use, on the prescription of an appropriate practitioner.

Drugs you administer yourself during treatment, most vaccines and injections given at the surgery, are exempt under VATA 1994 Schedule 9 Group 7, because they form part of a single supply of medical care. The same medicine can therefore carry a different liability depending on whether it is handed over or given, and your dispensary records are what shows which.

That medical-care exemption is the ordinary VAT position for the rest of a GP practice and it carries no input VAT recovery. How it is decided, and what falls outside it, sits on the guide to GP practice VAT registration.

Drugs dispensed against a private prescription are standard-rated, alongside the practice's other private and non-NHS income. Zero-rated dispensing income is taxable turnover, so it counts towards the £90,000 registration threshold while your exempt clinical income does not, and a registered practice with both is in partial exemption.

Which Dispensing Records Do You Need to Keep?

The dispensary's paperwork has to answer three different questions, and each one is answered by a different record.

The dispensing record, meaning what was dispensed, to whom and against which prescription, supports your reimbursement and fee claims and is what you check the payment statement against. The drug-purchase record, meaning what you bought, from whom and at what price, is the matching cost of sale. The stock record ties the two together at the year end, so that only the drugs dispensed during the year are charged against it.

Categorise each purchase and each supply as it happens. A dispensary that codes as it goes finds the accounts fall out of the records with little extra work at the year end, which is the day when the gaps are hardest to close. The day-to-day mechanics are in the GP bookkeeping guide, and how the records feed the year-end accounts is in the GP accounting guide.

Five Checks to Run on Your Own Dispensary

Each row is a check you can run this week against your own records, and what a failed check is costing you.

The check to run	What a failure means
Divide the dispensary's contribution by its dispensing turnover	Drawings set against gross turnover. On the illustration above that ratio is about 4%, so every £1,000 of dispensing turnover treated as spendable overdraws the practice by roughly £960
Ask the count sheets whether last year's stock was valued at purchase cost or at Tariff price	A count done on a different basis each year. If the sheets cannot answer, the comparatives are not comparable and the movement between them is not a real profit movement
Produce reimbursement, dispensing fees, drug purchases and the margin adjustment as four separate figures without reopening the bank statements	One nominal code for the whole dispensary. If the four figures will not come out, the gross margin cannot be calculated at all, only guessed
Trace a batch of administered drugs, most vaccines and injections, through your purchase coding	Administered drugs coded with dispensed drugs. This one costs cash, not presentation: it puts exempt-supply purchases into your input VAT recovery and misstates the taxable turnover you measure against the £90,000 registration threshold
Check a month's dispensing line against your own dispensing record, item by item	An unreconciled dispensing line. Prescriptions are priced against the Tariff for the dispensing month, so an item submitted late is paid at a different month's price, and nothing but this check will show it

This guide is general information and not advice for your specific circumstances. For tailored support, see our services for GPs or get in touch with our medical accounting team.

Related Reading

• GP Practice VAT Registration
• A GP Practice's Private and Non-NHS Income Streams
• Reading and Reconciling Your PCSE Statements
• GP Partnership Tax: Complete Guide
• GP Practice Management